Log In
Print this Print this

ezutromid (SMT C1100) (formerly BMN 195)

Also known as: formerly VOX C1100, VOXC 1100

  Manage Alerts
Collapse Summary General Information
Company Summit Therapeutics plc
DescriptionSmall molecule utrophin (UTRN) modulator
Molecular Target Utrophin (UTRN)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation U.S. - Fast Track (Treat Duchenne muscular dystrophy (DMD));
U.S. - Orphan Drug (Treat Duchenne muscular dystrophy (DMD));
U.S. - Rare Pediatric Disease (Treat Duchenne muscular dystrophy (DMD));
EU - Orphan Drug (Treat Duchenne muscular dystrophy (DMD))
PartnerSarepta Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today